We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market
Read MoreHide Full Article
In the latest trading session, Oscar Health, Inc. (OSCR - Free Report) closed at $13.30, marking a -1.92% move from the previous day. The stock's change was less than the S&P 500's daily loss of 0.28%. Meanwhile, the Dow lost 0.44%, and the Nasdaq, a tech-heavy index, lost 0.28%.
Prior to today's trading, shares of the company had lost 1.02% was narrower than the Finance sector's loss of 6.73% and the S&P 500's loss of 3.59%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's upcoming EPS is projected at $1.21, signifying a 31.52% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $4.89 billion, showing a 60.62% escalation compared to the year-ago quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.2 per share and a revenue of $18.91 billion, representing changes of +111.83% and +61.62%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #3 (Hold).
Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 66.69. For comparison, its industry has an average Forward P/E of 9.17, which means Oscar Health, Inc. is trading at a premium to the group.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 162, which puts it in the bottom 34% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market
In the latest trading session, Oscar Health, Inc. (OSCR - Free Report) closed at $13.30, marking a -1.92% move from the previous day. The stock's change was less than the S&P 500's daily loss of 0.28%. Meanwhile, the Dow lost 0.44%, and the Nasdaq, a tech-heavy index, lost 0.28%.
Prior to today's trading, shares of the company had lost 1.02% was narrower than the Finance sector's loss of 6.73% and the S&P 500's loss of 3.59%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's upcoming EPS is projected at $1.21, signifying a 31.52% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $4.89 billion, showing a 60.62% escalation compared to the year-ago quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.2 per share and a revenue of $18.91 billion, representing changes of +111.83% and +61.62%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #3 (Hold).
Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 66.69. For comparison, its industry has an average Forward P/E of 9.17, which means Oscar Health, Inc. is trading at a premium to the group.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 162, which puts it in the bottom 34% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.